Blinded: Placebo


Combined with:

Aspirin
Blinded: Saxagliptin
Metformin Hcl

Indications and Reactions:

Role Indications Reactions
Secondary
Type 2 Diabetes Mellitus 34.1%
Hypertension 11.1%
Non-small Cell Lung Cancer 10.1%
Prophylaxis 7.0%
Colorectal Cancer Metastatic 6.3%
Diabetes Mellitus 4.8%
Thrombosis Prophylaxis 3.4%
Schizophrenia 3.3%
Pain 2.8%
Rheumatoid Arthritis 2.7%
Malignant Melanoma 2.1%
Lung Neoplasm Malignant 2.0%
Premedication 1.5%
Gastrooesophageal Reflux Disease 1.4%
Constipation 1.4%
Nausea 1.4%
Cardiac Failure 1.3%
Cough 1.1%
Prostate Cancer 1.1%
Anxiety 1.1%
Pancreatitis 17.2%
Hypoglycaemia 8.4%
Renal Failure 8.4%
Vomiting 8.1%
Sepsis 6.6%
Pneumonia 5.9%
Thrombocytopenia 5.1%
Pancreatitis Acute 4.4%
Schizophrenia 4.0%
Septic Shock 4.0%
Renal Failure Acute 3.7%
Dehydration 2.9%
Gastritis 2.9%
Gastroenteritis 2.9%
Pancreatitis Chronic 2.6%
Prostate Cancer 2.6%
Psychotic Disorder 2.6%
Subileus 2.6%
Syncope 2.6%
Upper Gastrointestinal Haemorrhage 2.6%
Interacting
Diabetes Mellitus 23.1%
Type 2 Diabetes Mellitus 23.1%
Hypertension 15.4%
Atrial Fibrillation 7.7%
Coronary Artery Disease 7.7%
Diabetes Mellitus Non-insulin-dependent 7.7%
Hyperlipidaemia 7.7%
Vitamin D Deficiency 7.7%
Lung Carcinoma Cell Type Unspecified Recurrent 50.0%
Renal Failure Acute 50.0%

Drug Data